Rapid Micro Biosystems Inc (RPID)
1.25
-0.02
(-1.57%)
USD |
NASDAQ |
Nov 12, 16:00
1.25
0.00 (0.00%)
After-Hours: 20:00
Rapid Micro Biosystems Enterprise Value: -7.189M for Nov. 12, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2024 | -7.189M |
| November 11, 2024 | -6.331M |
| November 08, 2024 | -6.760M |
| November 07, 2024 | -7.618M |
| November 06, 2024 | -11.91M |
| November 05, 2024 | -14.06M |
| November 04, 2024 | -14.48M |
| November 01, 2024 | -13.63M |
| October 31, 2024 | -14.48M |
| October 30, 2024 | -13.20M |
| October 29, 2024 | -14.48M |
| October 28, 2024 | -14.91M |
| October 25, 2024 | -21.35M |
| October 24, 2024 | -21.78M |
| October 23, 2024 | -21.35M |
| October 22, 2024 | -22.64M |
| October 21, 2024 | -23.71M |
| October 18, 2024 | -22.81M |
| October 17, 2024 | -23.50M |
| October 16, 2024 | -23.50M |
| October 15, 2024 | -23.07M |
| October 14, 2024 | -22.81M |
| October 11, 2024 | -22.63M |
| October 10, 2024 | -23.02M |
| October 09, 2024 | -22.64M |
| Date | Value |
|---|---|
| October 08, 2024 | -22.21M |
| October 07, 2024 | -22.21M |
| October 04, 2024 | -22.21M |
| October 03, 2024 | -22.73M |
| October 02, 2024 | -23.11M |
| October 01, 2024 | -23.49M |
| September 30, 2024 | -22.64M |
| September 27, 2024 | -30.77M |
| September 26, 2024 | -30.85M |
| September 25, 2024 | -33.02M |
| September 24, 2024 | -33.23M |
| September 23, 2024 | -32.38M |
| September 20, 2024 | -31.67M |
| September 19, 2024 | -32.10M |
| September 18, 2024 | -33.34M |
| September 17, 2024 | -33.72M |
| September 16, 2024 | -33.51M |
| September 13, 2024 | -33.56M |
| September 12, 2024 | -33.06M |
| September 11, 2024 | -33.34M |
| September 10, 2024 | -33.84M |
| September 09, 2024 | -34.41M |
| September 06, 2024 | -33.56M |
| September 05, 2024 | -33.30M |
| September 04, 2024 | -33.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-68.40M
Minimum
Aug 09 2023
1.179B
Maximum
Aug 05 2021
81.56M
Average
-37.19M
Median
Enterprise Value Benchmarks
| Standard BioTools Inc | 453.87M |
| Ainos Inc | 9.823M |
| Zomedica Corp | 60.20M |
| LENSAR Inc | 67.97M |
| Intelligent Bio Solutions Inc | 2.267M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.32M |
| Revenue (Quarterly) | 7.604M |
| Total Expenses (Quarterly) | 19.64M |
| EPS Diluted (Quarterly) | -0.26 |
| Gross Profit Margin (Quarterly) | 8.18% |
| Profit Margin (Quarterly) | -148.9% |
| Earnings Yield | -89.60% |
| Normalized Earnings Yield | -89.60 |